Coming Soon!
Pharmacovigilance
One of our primary responsibilities is to provide consumers with high-quality, effective, and safe medicines, the benefits of which outweigh the risks. A Pharmacovigilance department has been established to monitor the safety and effectiveness of our medicines. When detecting adverse effects or unexpected side effects, our specialists are looking for the cause of their occurrence, and also do all possible to reduce and avoid the incidence of adverse medication reactions in the future. We would appreciate any information on the detection of any adverse drug reactions (ADR) or side effects, as well as inefficiency in the use of medications.
Introduction
Pharmacovigilance (PV) is defined by the World Health Organization (WHO) as the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problem.
Monitoring the safety of medicines includes all activities related to the detection, assessment, understanding, and prevention of adverse effects and other possible drug-related problems. This monitoring is carried out in a number of ways, including review and evaluation of suspected adverse reaction reports, published literature, epidemiological studies, and additional clinical trial results.
ESB continually assesses new and emerging safety data as it becomes available and undertakes regulatory action as appropriate. In addition to contributing to the safety profiles of existing drugs, pharmacovigilance activities help to improve the knowledge set and contribute to the breadth of epidemiological data.
Pharmacovigilance is therefore vital for the advancement of medical understanding, future research, and product development. Any improvements in safety or understanding will ultimately lead to improvements in patient care.